Envestnet Asset Management’s Coherus Oncology CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$257K Buy
+152,194
New +$270K ﹤0.01% 4372
2024
Q1
Sell
-11,892
Closed -$39.6K 4198
2023
Q4
$39.6K Sell
11,892
-10,258
-46% -$27.5K ﹤0.01% 3995
2023
Q3
$82.8K Buy
22,150
+5,857
+36% +$27.1K ﹤0.01% 3895
2023
Q2
$69.6K Sell
16,293
-840
-5% -$4.96K ﹤0.01% 3856
2023
Q1
$117K Buy
17,133
+1,154
+7% +$8.96K ﹤0.01% 3775
2022
Q4
$127K Sell
15,979
-8,212
-34% -$63.2K ﹤0.01% 3769
2022
Q3
$232K Buy
24,191
+6,345
+36% +$64.2K ﹤0.01% 3506
2022
Q2
$129K Sell
17,846
-1,122
-6% -$9.76K ﹤0.01% 3721
2022
Q1
$245K Sell
18,968
-7,221
-28% -$91.8K ﹤0.01% 3562
2021
Q4
$418K Buy
26,189
+3,136
+14% +$54.8K ﹤0.01% 3186
2021
Q3
$370K Buy
23,053
+2,346
+11% +$34.4K ﹤0.01% 3162
2021
Q2
$286K Buy
20,707
+257
+1% +$3.64K ﹤0.01% 3314
2021
Q1
$299K Sell
20,450
-173
-0.8% -$2.94K ﹤0.01% 3133
2020
Q4
$358K Buy
20,623
+6,884
+50% +$123K ﹤0.01% 2832
2020
Q3
$252K Sell
13,739
-496
-3% -$9.23K ﹤0.01% 2808
2020
Q2
$254K Sell
14,235
-35,742
-72% -$605K ﹤0.01% 2764
2020
Q1
$811K Buy
49,977
+4,798
+11% +$88.6K ﹤0.01% 1943
2019
Q4
$813K Buy
45,179
+2,476
+6% +$45.7K ﹤0.01% 2159
2019
Q3
$865K Buy
+42,703
New +$853K ﹤0.01% 2043
2018
Q3
Sell
-1,261
Closed -$18K 1469
2018
Q2
$18K Buy
1,261
+209
+20% +$2.99K ﹤0.01% 2442
2018
Q1
$12K Buy
1,052
+516
+96% +$5.64K ﹤0.01% 2461
2017
Q4
$5K Buy
+536
New +$5.74K ﹤0.01% 2735

Other funds holding CHRS